Form 8-K - Current report:
SEC Accession No. 0001520138-25-000083
Filing Date
2025-03-26
Accepted
2025-03-25 18:33:00
Documents
15
Period of Report
2025-03-23
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K esg-20250323_8k.htm   iXBRL 8-K 24843
2 EX-16 esg-20250323_8kex16z1.htm EX-16 3518
6 GRAPHIC image_01.jpg GRAPHIC 8239
  Complete submission text file 0001520138-25-000083.txt   208962

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE esgh-20250323.xsd EX-101.SCH 3009
4 XBRL LABEL FILE esgh-20250323_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE esgh-20250323_pre.xml EX-101.PRE 24161
17 EXTRACTED XBRL INSTANCE DOCUMENT esg-20250323_8k_htm.xml XML 3223
Mailing Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348
Business Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348 267-467-5871
ESG Inc. (Filer) CIK: 0001883835 (see all company filings)

EIN.: 871918342 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56532 | Film No.: 25769623
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)